{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:36:33Z","timestamp":1793957793267,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["31966"],"award-info":[{"award-number":["31966"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Phosphatidylserine (PS) exposure is increased in red cells from sickle cell anaemia (SCA) patients. Externalised PS is prothrombotic and attractive to phagocytes and activated endothelial cells and thus contributes to the anaemic and ischaemic complications of SCA. The mechanism of PS exposure remains uncertain but it can follow increased intracellular Ca<jats:sup>2+<\/jats:sup> concentration ([Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub>). Normally, [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub> is maintained at very low levels but in sickle cells, Ca<jats:sup>2+<\/jats:sup> permeability is increased, especially following deoxygenation and sickling, mediated by a pathway sometimes called P<jats:sub>sickle<\/jats:sub>. The molecular identity of P<jats:sub>sickle<\/jats:sub> is also unclear but recent work has implicated the mechanosensitive channel, PIEZO1. We used Yoda1, an PIEZO1 agonist, to investigate its role in sickle cells. Yoda1 caused an increase in [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub> and PS exposure, which was inhibited by its antagonist Dooku1 and the PIEZO1 inhibitor GsMTx4, consistent with functional PIEZO1. However, PS exposure did not necessitate an increase in [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub>. Two PKC inhibitors were also tested, chelerytherine chloride and calphostin C. Both reduced PS exposure whilst chelerytherine chloride also reduced Yoda1-induced increases in [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub>. Findings are therefore consistent with the presence of PIEZO1 in sickle cells, able to mediate Ca<jats:sup>2+<\/jats:sup> entry but that PKC was also involved in both Ca<jats:sup>2+<\/jats:sup> entry and PS exposure.<\/jats:p>","DOI":"10.1038\/s41598-020-76979-2","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T11:05:54Z","timestamp":1605697554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Yoda1 and phosphatidylserine exposure in red cells from patients with sickle cell anaemia"],"prefix":"10.1038","volume":"10","author":[{"given":"R.","family":"Wadud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hannemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. C.","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. N.","family":"Brewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"76979_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00018-005-4527-3","volume":"62","author":"RFA Zwaal","year":"2005","unstructured":"Zwaal, R. F. A., Comfurius, P. & Bevers, E. M. Surface exposure of phosphatidylserine in pathological cells. Cell. Mol. Life Sci. 62, 971\u2013988 (2005).","journal-title":"Cell. Mol. Life Sci."},{"key":"76979_CR2","doi-asserted-by":"publisher","first-page":"183231","DOI":"10.1016\/j.bbamem.2020.183231","volume":"1862","author":"A Koshkaryev","year":"2020","unstructured":"Koshkaryev, A. et al. Non-oxidative band-3 clustering agents cause the externalization of phosphatidylserine on erythrocyte surfaces by a calcium-independent mechanism. Biochim. Biophys. Acta 1862, 183231 (2020).","journal-title":"Biochim. Biophys. Acta"},{"key":"76979_CR3","doi-asserted-by":"crossref","unstructured":"Bernhardt, I., Nguyen, D. B., Wesseling, M. C. & Kaestner, L. Phosphatidylserine exposure in healthy human erythrocytes and dependence on in vivo cell age. Front. Physiol. 10, 1\u201310 (2020).","DOI":"10.3389\/fphys.2019.01629"},{"key":"76979_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2019.10.015","volume":"291","author":"A Catan","year":"2019","unstructured":"Catan, A. et al. Aging and glycation promote erythrocyte phagocytosis by human endothelial cells: Potential impact in atherothrombosis under diabetic conditions. Atherosclerosis 291, 87\u201398 (2019).","journal-title":"Atherosclerosis"},{"key":"76979_CR5","doi-asserted-by":"publisher","first-page":"12562","DOI":"10.1021\/bi025882o","volume":"41","author":"K de Jong","year":"2002","unstructured":"de Jong, K., Rettig, M. P., Low, P. S. & Kuypers, F. A. Protein kinase C activation induces phosphatidylserine exposure on red blood cells. Biochemistry 41, 12562\u201312567 (2002).","journal-title":"Biochemistry"},{"key":"76979_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ceca.2011.10.005","volume":"51","author":"E Weiss","year":"2012","unstructured":"Weiss, E. et al. Deoxygenation-induced and Ca2+-dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients. Cell Calcium 51, 51\u201356 (2012).","journal-title":"Cell Calcium"},{"key":"76979_CR7","first-page":"1","volume-title":"Red Cell Membrane Transport in Health and Disease","author":"CWM Haest","year":"2003","unstructured":"Haest, C. W. M. Distribution and movement of membrane lipids. In Red Cell Membrane Transport in Health and Disease (eds Bernhardt, I. & Ellory, J. C.) 1\u201325 (Springer, Berlin, 2003)."},{"key":"76979_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/00062752-199803000-00007","volume":"5","author":"FA Kuypers","year":"1998","unstructured":"Kuypers, F. A. Phospholipid asymmetry in health and disease. Curr. Opin. Hematol. 5, 122\u2013131 (1998).","journal-title":"Curr. Opin. Hematol."},{"key":"76979_CR9","first-page":"2489","volume":"92","author":"Z Etzion","year":"1992","unstructured":"Etzion, Z., Fiffert, T., Lew, V. L. & Bookchin, R. M. Deoxygenation increases [Ca2+]I in sickle cell anemia discocyes by Ca2+ pump inhibition as well as increased Ca2+ permeability. Blood 92, 2489\u20132498 (1992).","journal-title":"Blood"},{"key":"76979_CR10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/0006-3002(58)90124-0","volume":"30","author":"G G\u00e1rdos","year":"1958","unstructured":"G\u00e1rdos, G. The function of calcium in the potassium permeability of human erythrocytes. Biochim. Biophys. Acta 30, 653\u2013654 (1958).","journal-title":"Biochim. Biophys. Acta"},{"key":"76979_CR11","volume-title":"Hemoglobin: Molecular, Genetic and Clinical Aspects","author":"HF Bunn","year":"1986","unstructured":"Bunn, H. F. & Forget, B. G. Hemoglobin: Molecular, Genetic and Clinical Aspects (W. B. Saunders Company, Philadelphia, 1986)."},{"key":"76979_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1006\/bcmd.2002.0515","volume":"28","author":"JS Gibson","year":"2002","unstructured":"Gibson, J. S. & Ellory, J. C. Membrane transport in sickle cell disease. Blood Cells Mol. Dis. 28, 303\u2013314 (2002).","journal-title":"Blood Cells Mol. Dis."},{"key":"76979_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1152\/physrev.00052.2003","volume":"85","author":"VL Lew","year":"2005","unstructured":"Lew, V. L. & Bookchin, R. M. Ion transport pathology in the mechanism of sickle cell dehydration. Physiol. Rev. 85, 179\u2013200 (2005).","journal-title":"Physiol. Rev."},{"key":"76979_CR14","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1182\/blood.V70.5.1245.1245","volume":"70b","author":"JW Eaton","year":"1987","unstructured":"Eaton, J. W. & Hofrichter, J. Hemoglobin S gelation and sickle cell disease. Blood 70b, 1245\u20131266 (1987).","journal-title":"Blood"},{"key":"76979_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1182\/blood.V68.2.450.450","volume":"68","author":"N Mohandas","year":"1986","unstructured":"Mohandas, N., Rossi, M. E. & Clark, M. R. Association between morphologic distortion of sickle cells and deoxygenation-induced cation permeability increases. Blood 68, 450\u2013454 (1986).","journal-title":"Blood"},{"key":"76979_CR16","doi-asserted-by":"publisher","first-page":"C251","DOI":"10.1152\/ajpcell.1993.264.2.C251","volume":"264","author":"CH Joiner","year":"1993","unstructured":"Joiner, C. H. Cation transport and volume regulation in sickle red blood cells. Am. J. Physiol. 264, C251\u2013C270 (1993).","journal-title":"Am. J. Physiol."},{"key":"76979_CR17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1182\/blood.V77.4.849.849","volume":"77","author":"N Blumenfeld","year":"1991","unstructured":"Blumenfeld, N., Zachowski, A., Galacteros, F., Beuzard, Y. & Devaux, P. F. Transmembrane mobility of phospholipids in sickle erythrcoytes: Effect of deoxygenation on diffusion and asymmetry. Blood 77, 849\u2013854 (1991).","journal-title":"Blood"},{"key":"76979_CR18","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00424-013-1308-y","volume":"465","author":"UM Cytlak","year":"2013","unstructured":"Cytlak, U. M., Hannemann, A., Rees, D. C. & Gibson, J. S. Identification of the Ca2+ entry pathway involved in deoxygenation-induced phosphatidylserine exposure in red blood cells from patients with sickle cell disease. Pflug. Archiv. Eur. J. Physiol. 465, 1651\u20131660 (2013).","journal-title":"Pflug. Archiv. Eur. J. Physiol."},{"key":"76979_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1517\/13543780802708011","volume":"18","author":"KI Ataga","year":"2009","unstructured":"Ataga, K. I. & Stocker, J. Senicapoc (ICA-17043): A potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia. Expert Opin. Investig. Drugs 18, 231\u2013239 (2009).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"76979_CR20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/978-3-030-12457-1_25","volume":"1131","author":"L Kaestner","year":"2020","unstructured":"Kaestner, L., Bogdanova, A. & Egee, S. Calcium channels and calcium-regulated channels in human red blood cells. Adv. Exp. Med. Biol. 1131, 625\u2013648 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"76979_CR21","doi-asserted-by":"publisher","first-page":"e07370","DOI":"10.7554\/eLife.07370","volume":"4","author":"SM Calahan","year":"2015","unstructured":"Calahan, S. M. et al. Piezo1 links mechanical forces to red blood cell volume. eLife 4, e07370 (2015).","journal-title":"eLife"},{"key":"76979_CR22","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1182\/blood-2012-04-422253","volume":"120","author":"R Zarychanski","year":"2012","unstructured":"Zarychanski, R. et al. Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis. Blood 120, 1908\u20131915 (2012).","journal-title":"Blood"},{"key":"76979_CR23","doi-asserted-by":"publisher","first-page":"E1162","DOI":"10.1073\/pnas.1219777110","volume":"110","author":"C Bae","year":"2013","unstructured":"Bae, C., Gnanasambandam, R., Nicolai, C., Sachs, F. & Gottlieb, P. A. Xerocytosis is caused by mutations that alter the kinetics of the mechanosensitive channel PIEZO1. Proc. Natl. Acad. Sci. USA 110, E1162\u2013E1168 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76979_CR24","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3324\/haematol.2018.205328","volume":"104","author":"V Picard","year":"2019","unstructured":"Picard, V. et al. Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: A retrospective series of 126 patients. Haematologica 104, 1554\u20131564 (2019).","journal-title":"Haematologica"},{"key":"76979_CR25","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1182\/blood-2013-02-482489","volume":"212","author":"I Andolfo","year":"2013","unstructured":"Andolfo, I. et al. Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1. Blood 212, 3925\u20133935 (2013).","journal-title":"Blood"},{"key":"76979_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/ajh.24929","volume":"93","author":"I Andolfo","year":"2018","unstructured":"Andolfo, I., Russo, R., Gambale, A. & Iolascon, A. Hereditary stomatocytosis: An underdiagnosed condition. Am. J. Hematol. 93, 107\u2013121 (2018).","journal-title":"Am. J. Hematol."},{"key":"76979_CR27","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1038\/ncomms2899","volume":"4","author":"J Albuisson","year":"2013","unstructured":"Albuisson, J. et al. Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels. Nat. Commun. 4, 1884 (2013).","journal-title":"Nat. Commun."},{"key":"76979_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cell.2018.02.047","volume":"173","author":"S Ma","year":"2018","unstructured":"Ma, S. et al. Common PIEZO1 allele in African populations causes RBC dehydration and attenuates Plasmodium infection. Cell 173, 443\u2013455 (2018).","journal-title":"Cell"},{"key":"76979_CR29","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.3324\/haematol.2018.202697","volume":"104","author":"H Rooks","year":"2019","unstructured":"Rooks, H. et al. A gain of function variant in PIEZO1 (E756del) and sickle cell disease. Haematologica 104, e91 (2019).","journal-title":"Haematologica"},{"key":"76979_CR30","doi-asserted-by":"publisher","first-page":"e07369","DOI":"10.7554\/eLife.07369","volume":"4","author":"R Syeda","year":"2015","unstructured":"Syeda, R. et al. Chemical activation of the mechanotransduction channel Piezo1. eLife 4, e07369 (2015).","journal-title":"eLife"},{"key":"76979_CR31","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/bph.14188","volume":"175","author":"EL Evans","year":"2018","unstructured":"Evans, E. L. et al. Yoda1 analogue (Dooku1) which antagonises Yoda1-evoked activation of Piezo1 and aortic relaxation. Br. J. Pharmacol. 175, 1744\u20131759 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"76979_CR32","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41467-018-03570-9","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. A lever-like transduction pathway for long-distance chemical- and mechano-gating of the mechanosensitive Piezo1 channel. Nat. Commun. 9, 1300 (2018).","journal-title":"Nat. Commun."},{"key":"76979_CR33","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1038\/s41467-019-12501-1","volume":"10","author":"WM Botello-Smith","year":"2019","unstructured":"Botello-Smith, W. M. et al. A mechanism for the activation of the mechanosensitive Piezo1 channel by the small molecules Yoda1. Nat. Commun. 10, 4503 (2019).","journal-title":"Nat. Commun."},{"key":"76979_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbrc.2018.02.058","volume":"497","author":"NG Dela Paz","year":"2018","unstructured":"Dela Paz, N. G. & Frangos, J. A. Yoda1-induced phosphorylation of Akt and ERK1\/2 does not require Piezo1 activation. Biochem. Biophys. Res. Commun. 497, 220\u2013225 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"76979_CR35","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1159\/000335798","volume":"28","author":"DB Nguyen","year":"2011","unstructured":"Nguyen, D. B. et al. Regulation of phosphatidylserine exposure in red blood cells. Cell. Physiol. Biochem. 28, 847\u2013856 (2011).","journal-title":"Cell. Physiol. Biochem."},{"key":"76979_CR36","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1159\/000447891","volume":"39","author":"MC Wesseling","year":"2016","unstructured":"Wesseling, M. C. et al. Novel insights in the regulation of phopshatidylserine exposure in human red blood cells. Cell. Physiol. Biochem. 39, 1941\u20131954 (2016).","journal-title":"Cell. Physiol. Biochem."},{"key":"76979_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/bjh.15441","volume":"182","author":"A Hannemann","year":"2018","unstructured":"Hannemann, A. et al. Oxidative stress and phosphatidylserine exposure in red cells from patients with sickle cell anaemia. Br. J. Haematol. 182, 567\u2013578 (2018).","journal-title":"Br. J. Haematol."},{"key":"76979_CR38","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1172\/JCI119462","volume":"99","author":"VL Lew","year":"1997","unstructured":"Lew, V. L. & Bookchin, R. M. Stochastic nature and red cell population distribution of the sickling-induced Ca2+ permeability. J. Clin. Investig. 99, 2727\u20132735 (1997).","journal-title":"J. Clin. Investig."},{"key":"76979_CR39","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1159\/000350106","volume":"31","author":"L Wagner-Britz","year":"2013","unstructured":"Wagner-Britz, L., Wang, J., Kaestner, L. & Bernhardt, I. Protein kinase C\u03b1 and P-type Ca2+ channel Cav2.1 in red blood cell calcium signalling. Cell. Physiol. Biochem. 31, 883\u2013891 (2013).","journal-title":"Cell. Physiol. Biochem."},{"key":"76979_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/00062752-199903000-00004","volume":"6","author":"D Andrews","year":"1999","unstructured":"Andrews, D. & Low, P. S. Role of red blood cells in thrombosis. Curr. Opin. Hematol. 6, 76\u201382 (1999).","journal-title":"Curr. Opin. Hematol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76979-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76979-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76979-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:44:04Z","timestamp":1670370244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76979-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["76979"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-76979-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"assertion":[{"value":"25 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20110"}}